Many employers moving to Level-Funded Health Plans gain greater visibility into claims data while creating additional opportunities for long-term cost management
For the first time in history, new drugs could prove to be the game changer to stem the tide of people living with obesity, an epidemic which has grown exponentially since the 1970s, costing $173 billion per year in medical costs in the United States alone
- zum Ausgleich von behandlungsbedingten Levocarnitin-Verlusten, welche als Folge einer Dauerbehandlung durch Blutwsche bei Patienten mit Nierenversagen entstehen knnen (Substitution dialysebedingter Levocarnitin-Verluste bei chronischer Hmodialyse, d.h
The GRADE trial provides some insights, reporting a cardiovascular benefit with liraglutide
IVIM offers phone support at (877) 581-2210 Monday through Friday, 8 a.m
In this blog, we will explain why some people regain weight after stopping GLP-1 medications and what you can do to improve your chances of maintaining your results